BioSpace News Archive

Press Releases

Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity

June 7, 2026
·
9 min read
Press Releases

Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8

June 7, 2026
·
2 min read
Press Releases

Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

June 7, 2026
·
4 min read
Press Releases

AbCellera Appoints Dr. Victor Sandor to its Board of Directors

June 7, 2026
·
2 min read
Press Releases

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 5, 2026

June 7, 2026
·
2 min read
Press Releases

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 5, 2026

June 7, 2026
·
2 min read
Press Releases

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 5, 2026

June 7, 2026
·
1 min read
Press Releases

Spyre Therapeutics Announces Grants of Inducement Awards - June 5, 2026

June 7, 2026
·
1 min read
Press Releases

New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people living with overweight and obesity

June 7, 2026
·
10 min read
Press Releases

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - June 5, 2026

June 7, 2026
·
4 min read